These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25663016)

  • 1. Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach.
    Aboye T; Kuang Y; Neamati N; Camarero JA
    Chembiochem; 2015 Mar; 16(5):827-33. PubMed ID: 25663016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent.
    Lesniak WG; Aboye T; Chatterjee S; Camarero JA; Nimmagadda S
    Chemistry; 2017 Oct; 23(58):14469-14475. PubMed ID: 28771849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidation of a bioactive cyclotide-based CXCR4 antagonist greatly improves its pharmacokinetic profile in vivo.
    Chaudhuri D; Lu T; Jacob B; Abraham S; Shankar P; Poss MA; Neamati N; Camarero JA
    J Control Release; 2023 Jul; 359():26-32. PubMed ID: 37236320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases.
    Schmidt M; Huang YH; Texeira de Oliveira EF; Toplak A; Wijma HJ; Janssen DB; van Maarseveen JH; Craik DJ; Nuijens T
    Chembiochem; 2019 Jun; 20(12):1524-1529. PubMed ID: 30735312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.
    Eliasen R; Daly NL; Wulff BS; Andresen TL; Conde-Frieboes KW; Craik DJ
    J Biol Chem; 2012 Nov; 287(48):40493-501. PubMed ID: 23012369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity.
    Aboye TL; Ha H; Majumder S; Christ F; Debyser Z; Shekhtman A; Neamati N; Camarero JA
    J Med Chem; 2012 Dec; 55(23):10729-34. PubMed ID: 23151033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2.
    Leta Aboye T; Clark RJ; Craik DJ; Göransson U
    Chembiochem; 2008 Jan; 9(1):103-13. PubMed ID: 18058973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Synthesis and Functional Analysis of VarvA Cyclotide.
    Álvarez CA; Santana PA; Luna O; Cárdenas C; Albericio F; Romero MS; Guzmán F
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29671790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular Permutation of the Native Enzyme-Mediated Cyclization Position in Cyclotides.
    Smithies BJ; Huang YH; Jackson MA; Yap K; Gilding EK; Harris KS; Anderson MA; Craik DJ
    ACS Chem Biol; 2020 Apr; 15(4):962-969. PubMed ID: 32203656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal oxidative folding of the novel antimicrobial cyclotide from Hedyotis biflora requires high alcohol concentrations.
    Wong CT; Taichi M; Nishio H; Nishiuchi Y; Tam JP
    Biochemistry; 2011 Aug; 50(33):7275-83. PubMed ID: 21776968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclotides and related macrocyclic peptides as scaffolds in drug design.
    Craik DJ; Cemazar M; Daly NL
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):251-60. PubMed ID: 16566295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Expression and Phenotypic Screening of a Bioactive Cyclotide Against α-Synuclein-Induced Cytotoxicity in Baker's Yeast.
    Jagadish K; Gould A; Borra R; Majumder S; Mushtaq Z; Shekhtman A; Camarero JA
    Angew Chem Int Ed Engl; 2015 Jul; 54(29):8390-4. PubMed ID: 26096948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic On-Resin Peptide Cleavage and in Situ Cyclization One-Pot Strategy for the Synthesis of Cyclopeptide and Cyclotide.
    Cheng X; Hong H; Zhou Z; Wu Z
    J Org Chem; 2018 Nov; 83(22):14078-14083. PubMed ID: 30277068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic potency of small macrocyclic knot proteins: structure-activity and mechanistic studies of native and chemically modified cyclotides.
    Burman R; Herrmann A; Tran R; Kivelä JE; Lomize A; Gullbo J; Göransson U
    Org Biomol Chem; 2011 Jun; 9(11):4306-14. PubMed ID: 21491023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclotides as a basis for drug design.
    Craik DJ; Swedberg JE; Mylne JS; Cemazar M
    Expert Opin Drug Discov; 2012 Mar; 7(3):179-94. PubMed ID: 22468950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fmoc-based synthesis of disulfide-rich cyclic peptides.
    Cheneval O; Schroeder CI; Durek T; Walsh P; Huang YH; Liras S; Price DA; Craik DJ
    J Org Chem; 2014 Jun; 79(12):5538-44. PubMed ID: 24918986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemistry and biology of cyclotides.
    Craik DJ; Cemazar M; Daly NL
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):176-84. PubMed ID: 17436553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemistry of cyclotides.
    Craik DJ; Conibear AC
    J Org Chem; 2011 Jun; 76(12):4805-17. PubMed ID: 21526790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclotides: a patent review.
    Smith AB; Daly NL; Craik DJ
    Expert Opin Ther Pat; 2011 Nov; 21(11):1657-72. PubMed ID: 22017409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity.
    Aboye T; Meeks CJ; Majumder S; Shekhtman A; Rodgers K; Camarero JA
    Molecules; 2016 Jan; 21(2):152. PubMed ID: 26821010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.